Join QRC Consultants for their second seminar in the 2015 series: "The Changing Face of Clinical Drug Development in Europe" on Tuesday 23 June 2015.
Speakers include:
- Sarah Fryer, Director QRCC
- Dr Sarah Nicholson, Principal Regulatory Consultant QRCC
- Rob Johnson, Partner, Alacrita
- Dr William (Bill) Slichenmyer, Partner, Alacrita.
Topics to be covered include:
- Changing regulatory environment
- Financial incentives on offer in the EU
- Advantages for clinical development in the EU
Date : Tuesday 23 June 2015 9:00am
Venue: British Consulate, One Broadway, 7th Floor, Cambridge Massachusetts, USA
Cost: FREE
To book your place please contact enquiries@qrcc.co.uk
About QRC Consultants Ltd
QRC Consultants Ltd is a team of experienced QA, regulatory and clinical research professionals, dedicated to providing high quality, practical, responsive and cost effective services to support biotechnology and pharmaceutical companies primarily with early stage clinical development.
For further information, please see www.qrcc.co.uk or email enquiries@qrcc.co.uk
_____________________________________